A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies
瑞戈非尼治疗晚期髓系恶性肿瘤的非随机 I 期和生物标志物试验
期刊:eJHaem
影响因子:
doi:10.1002/jha2.408
Joan How, Siyang Ren, Jennifer Lombardi-Story, Meghan Bergeron, Julia Foster, Phillip C Amrein, Andrew M Brunner, Amir T Fathi, Hanno Hock, Anna Khachatryan, Hiroto Kikuchi, Mei Rosa Ng, Jenna Moran, Rupa Narayan, Donna Neuberg, Aura Ramos, Tina Som, Meghan Vartanian, Yi-Bin Chen, Dan G Duda, Gabrie